Regorafenib for the Treatment of Sarcoma
Year: 2022
Type: review
Institutions: Centre Léon Bérard, Aix-Marseille Université, Hôpital de la Timone, Harvard University, Dana-Farber Cancer Institute, University of Pennsylvania, Université de Lille, Centre Hospitalier Universitaire de Lille, Centre Oscar Lambret, Hôpital Claude Huriez, Evaluation des technologies de santé et des pratiques médicales
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bayer
OpenAlex ID: W4298086480